nodes	percent_of_prediction	percent_of_DWPC	metapath
Epinephrine—CYP3A4—bone cancer	0.708	1	CbGaD
Epinephrine—Extravasation—Carboplatin—bone cancer	0.0072	0.0587	CcSEcCtD
Epinephrine—Skin necrosis—Cisplatin—bone cancer	0.00528	0.043	CcSEcCtD
Epinephrine—Tachyarrhythmia—Epirubicin—bone cancer	0.00518	0.0422	CcSEcCtD
Epinephrine—Tachyarrhythmia—Doxorubicin—bone cancer	0.0048	0.0391	CcSEcCtD
Epinephrine—Lactic acidosis—Epirubicin—bone cancer	0.00388	0.0316	CcSEcCtD
Epinephrine—Lactic acidosis—Doxorubicin—bone cancer	0.00359	0.0292	CcSEcCtD
Epinephrine—SLC22A2—Cisplatin—bone cancer	0.00293	0.724	CbGbCtD
Epinephrine—Skin necrosis—Methotrexate—bone cancer	0.00289	0.0236	CcSEcCtD
Epinephrine—Skin necrosis—Epirubicin—bone cancer	0.00271	0.0221	CcSEcCtD
Epinephrine—Hemiplegia—Epirubicin—bone cancer	0.00265	0.0216	CcSEcCtD
Epinephrine—Skin necrosis—Doxorubicin—bone cancer	0.00251	0.0204	CcSEcCtD
Epinephrine—Rales—Methotrexate—bone cancer	0.00247	0.0201	CcSEcCtD
Epinephrine—Hemiplegia—Doxorubicin—bone cancer	0.00245	0.02	CcSEcCtD
Epinephrine—Necrosis—Cisplatin—bone cancer	0.00235	0.0191	CcSEcCtD
Epinephrine—Nephropathy—Methotrexate—bone cancer	0.00212	0.0173	CcSEcCtD
Epinephrine—Extravasation—Cisplatin—bone cancer	0.00211	0.0172	CcSEcCtD
Epinephrine—Skin exfoliation—Cisplatin—bone cancer	0.00176	0.0143	CcSEcCtD
Epinephrine—Local reaction—Epirubicin—bone cancer	0.00171	0.0139	CcSEcCtD
Epinephrine—Local reaction—Doxorubicin—bone cancer	0.00158	0.0129	CcSEcCtD
Epinephrine—Cerebrovascular accident—Cisplatin—bone cancer	0.00137	0.0111	CcSEcCtD
Epinephrine—Necrosis—Methotrexate—bone cancer	0.00129	0.0105	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Epirubicin—bone cancer	0.00128	0.0104	CcSEcCtD
Epinephrine—Hypokalaemia—Cisplatin—bone cancer	0.00122	0.00992	CcSEcCtD
Epinephrine—Necrosis—Epirubicin—bone cancer	0.00121	0.00982	CcSEcCtD
Epinephrine—Ventricular arrhythmia—Doxorubicin—bone cancer	0.00118	0.00964	CcSEcCtD
Epinephrine—Extravasation—Methotrexate—bone cancer	0.00116	0.00944	CcSEcCtD
Epinephrine—Sweating increased—Cisplatin—bone cancer	0.00113	0.00917	CcSEcCtD
Epinephrine—Necrosis—Doxorubicin—bone cancer	0.00112	0.00909	CcSEcCtD
Epinephrine—Extravasation—Epirubicin—bone cancer	0.00108	0.00884	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Epirubicin—bone cancer	0.00105	0.00853	CcSEcCtD
Epinephrine—Acute coronary syndrome—Cisplatin—bone cancer	0.00102	0.00828	CcSEcCtD
Epinephrine—Renal failure—Cisplatin—bone cancer	0.00101	0.00825	CcSEcCtD
Epinephrine—Myocardial infarction—Cisplatin—bone cancer	0.00101	0.00823	CcSEcCtD
Epinephrine—Extravasation—Doxorubicin—bone cancer	0.001	0.00818	CcSEcCtD
Epinephrine—Ventricular extrasystoles—Doxorubicin—bone cancer	0.00097	0.0079	CcSEcCtD
Epinephrine—Skin exfoliation—Methotrexate—bone cancer	0.000966	0.00786	CcSEcCtD
Epinephrine—Skin exfoliation—Epirubicin—bone cancer	0.000904	0.00736	CcSEcCtD
Epinephrine—Pulmonary oedema—Methotrexate—bone cancer	0.0009	0.00733	CcSEcCtD
Epinephrine—Flushing—Cisplatin—bone cancer	0.000859	0.007	CcSEcCtD
Epinephrine—Pulmonary oedema—Epirubicin—bone cancer	0.000843	0.00686	CcSEcCtD
Epinephrine—Skin exfoliation—Doxorubicin—bone cancer	0.000836	0.00681	CcSEcCtD
Epinephrine—Arrhythmia—Cisplatin—bone cancer	0.000827	0.00673	CcSEcCtD
Epinephrine—Erythema—Cisplatin—bone cancer	0.000806	0.00656	CcSEcCtD
Epinephrine—CYP2C9—Cisplatin—bone cancer	0.000805	0.199	CbGbCtD
Epinephrine—Pulmonary oedema—Doxorubicin—bone cancer	0.00078	0.00635	CcSEcCtD
Epinephrine—Cerebrovascular accident—Methotrexate—bone cancer	0.000749	0.0061	CcSEcCtD
Epinephrine—Renal impairment—Epirubicin—bone cancer	0.000722	0.00588	CcSEcCtD
Epinephrine—Hypoglycaemia—Epirubicin—bone cancer	0.000704	0.00573	CcSEcCtD
Epinephrine—Cerebrovascular accident—Epirubicin—bone cancer	0.000701	0.00571	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—bone cancer	0.000681	0.00555	CcSEcCtD
Epinephrine—Renal impairment—Doxorubicin—bone cancer	0.000668	0.00544	CcSEcCtD
Epinephrine—Hypoglycaemia—Doxorubicin—bone cancer	0.000651	0.00531	CcSEcCtD
Epinephrine—Cerebrovascular accident—Doxorubicin—bone cancer	0.000649	0.00528	CcSEcCtD
Epinephrine—Nervous system disorder—Cisplatin—bone cancer	0.000645	0.00525	CcSEcCtD
Epinephrine—Tachycardia—Cisplatin—bone cancer	0.000642	0.00523	CcSEcCtD
Epinephrine—Skin disorder—Cisplatin—bone cancer	0.000639	0.0052	CcSEcCtD
Epinephrine—Hyperhidrosis—Cisplatin—bone cancer	0.000636	0.00518	CcSEcCtD
Epinephrine—Hypokalaemia—Epirubicin—bone cancer	0.000625	0.00509	CcSEcCtD
Epinephrine—Paraesthesia—Cisplatin—bone cancer	0.000591	0.00481	CcSEcCtD
Epinephrine—Hypokalaemia—Doxorubicin—bone cancer	0.000579	0.00471	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000568	0.00462	CcSEcCtD
Epinephrine—Drowsiness—Methotrexate—bone cancer	0.000566	0.00461	CcSEcCtD
Epinephrine—Renal failure—Methotrexate—bone cancer	0.000556	0.00453	CcSEcCtD
Epinephrine—Sweating—Methotrexate—bone cancer	0.000542	0.00442	CcSEcCtD
Epinephrine—Hyperglycaemia—Epirubicin—bone cancer	0.000536	0.00436	CcSEcCtD
Epinephrine—Drowsiness—Epirubicin—bone cancer	0.00053	0.00431	CcSEcCtD
Epinephrine—Renal failure—Epirubicin—bone cancer	0.000521	0.00424	CcSEcCtD
Epinephrine—Haemoglobin—Methotrexate—bone cancer	0.000511	0.00416	CcSEcCtD
Epinephrine—Haemorrhage—Methotrexate—bone cancer	0.000508	0.00414	CcSEcCtD
Epinephrine—Sweating—Epirubicin—bone cancer	0.000508	0.00413	CcSEcCtD
Epinephrine—Hyperglycaemia—Doxorubicin—bone cancer	0.000496	0.00404	CcSEcCtD
Epinephrine—Drowsiness—Doxorubicin—bone cancer	0.00049	0.00399	CcSEcCtD
Epinephrine—Renal failure—Doxorubicin—bone cancer	0.000482	0.00392	CcSEcCtD
Epinephrine—Haemoglobin—Epirubicin—bone cancer	0.000478	0.00389	CcSEcCtD
Epinephrine—Haemorrhage—Epirubicin—bone cancer	0.000475	0.00387	CcSEcCtD
Epinephrine—Hypoaesthesia—Epirubicin—bone cancer	0.000473	0.00385	CcSEcCtD
Epinephrine—Sweating—Doxorubicin—bone cancer	0.00047	0.00383	CcSEcCtD
Epinephrine—Mental disorder—Methotrexate—bone cancer	0.000445	0.00362	CcSEcCtD
Epinephrine—Erythema—Methotrexate—bone cancer	0.000442	0.0036	CcSEcCtD
Epinephrine—Haemoglobin—Doxorubicin—bone cancer	0.000442	0.0036	CcSEcCtD
Epinephrine—Flushing—Epirubicin—bone cancer	0.000441	0.00359	CcSEcCtD
Epinephrine—Haemorrhage—Doxorubicin—bone cancer	0.00044	0.00358	CcSEcCtD
Epinephrine—Hypoaesthesia—Doxorubicin—bone cancer	0.000438	0.00356	CcSEcCtD
Epinephrine—Arrhythmia—Epirubicin—bone cancer	0.000425	0.00346	CcSEcCtD
Epinephrine—Vomiting—Cisplatin—bone cancer	0.000418	0.00341	CcSEcCtD
Epinephrine—Mental disorder—Epirubicin—bone cancer	0.000416	0.00339	CcSEcCtD
Epinephrine—Erythema—Epirubicin—bone cancer	0.000414	0.00337	CcSEcCtD
Epinephrine—Flushing—Doxorubicin—bone cancer	0.000408	0.00332	CcSEcCtD
Epinephrine—Tension—Epirubicin—bone cancer	0.000406	0.00331	CcSEcCtD
Epinephrine—Nervousness—Epirubicin—bone cancer	0.000402	0.00327	CcSEcCtD
Epinephrine—Arrhythmia—Doxorubicin—bone cancer	0.000393	0.0032	CcSEcCtD
Epinephrine—Nausea—Cisplatin—bone cancer	0.000391	0.00318	CcSEcCtD
Epinephrine—Mental disorder—Doxorubicin—bone cancer	0.000385	0.00314	CcSEcCtD
Epinephrine—Erythema—Doxorubicin—bone cancer	0.000383	0.00312	CcSEcCtD
Epinephrine—Agitation—Epirubicin—bone cancer	0.00038	0.0031	CcSEcCtD
Epinephrine—Chest pain—Methotrexate—bone cancer	0.000376	0.00307	CcSEcCtD
Epinephrine—Tension—Doxorubicin—bone cancer	0.000376	0.00306	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—bone cancer	0.000374	0.00304	CcSEcCtD
Epinephrine—Nervousness—Doxorubicin—bone cancer	0.000372	0.00303	CcSEcCtD
Epinephrine—Palpitations—Epirubicin—bone cancer	0.000366	0.00298	CcSEcCtD
Epinephrine—Hypertension—Epirubicin—bone cancer	0.000357	0.00291	CcSEcCtD
Epinephrine—Nervous system disorder—Methotrexate—bone cancer	0.000354	0.00288	CcSEcCtD
Epinephrine—Chest pain—Epirubicin—bone cancer	0.000352	0.00287	CcSEcCtD
Epinephrine—Agitation—Doxorubicin—bone cancer	0.000352	0.00287	CcSEcCtD
Epinephrine—Skin disorder—Methotrexate—bone cancer	0.000351	0.00285	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—bone cancer	0.00035	0.00285	CcSEcCtD
Epinephrine—Hyperhidrosis—Methotrexate—bone cancer	0.000349	0.00284	CcSEcCtD
Epinephrine—Palpitations—Doxorubicin—bone cancer	0.000338	0.00276	CcSEcCtD
Epinephrine—Nervous system disorder—Epirubicin—bone cancer	0.000331	0.0027	CcSEcCtD
Epinephrine—Hypertension—Doxorubicin—bone cancer	0.000331	0.00269	CcSEcCtD
Epinephrine—Tachycardia—Epirubicin—bone cancer	0.00033	0.00268	CcSEcCtD
Epinephrine—Skin disorder—Epirubicin—bone cancer	0.000328	0.00267	CcSEcCtD
Epinephrine—Hyperhidrosis—Epirubicin—bone cancer	0.000326	0.00266	CcSEcCtD
Epinephrine—Insomnia—Methotrexate—bone cancer	0.000326	0.00266	CcSEcCtD
Epinephrine—Chest pain—Doxorubicin—bone cancer	0.000326	0.00265	CcSEcCtD
Epinephrine—Paraesthesia—Methotrexate—bone cancer	0.000324	0.00264	CcSEcCtD
Epinephrine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—bone cancer	0.000324	0.00264	CcSEcCtD
Epinephrine—Somnolence—Methotrexate—bone cancer	0.000321	0.00261	CcSEcCtD
Epinephrine—CYP3A4—Doxorubicin—bone cancer	0.000314	0.0774	CbGbCtD
Epinephrine—Gastrointestinal disorder—Methotrexate—bone cancer	0.000312	0.00254	CcSEcCtD
Epinephrine—Nervous system disorder—Doxorubicin—bone cancer	0.000306	0.0025	CcSEcCtD
Epinephrine—Insomnia—Epirubicin—bone cancer	0.000305	0.00249	CcSEcCtD
Epinephrine—Tachycardia—Doxorubicin—bone cancer	0.000305	0.00248	CcSEcCtD
Epinephrine—Skin disorder—Doxorubicin—bone cancer	0.000304	0.00247	CcSEcCtD
Epinephrine—Paraesthesia—Epirubicin—bone cancer	0.000303	0.00247	CcSEcCtD
Epinephrine—Hyperhidrosis—Doxorubicin—bone cancer	0.000302	0.00246	CcSEcCtD
Epinephrine—Somnolence—Epirubicin—bone cancer	0.0003	0.00245	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Epirubicin—bone cancer	0.000292	0.00237	CcSEcCtD
Epinephrine—Insomnia—Doxorubicin—bone cancer	0.000283	0.0023	CcSEcCtD
Epinephrine—Paraesthesia—Doxorubicin—bone cancer	0.000281	0.00229	CcSEcCtD
Epinephrine—Somnolence—Doxorubicin—bone cancer	0.000278	0.00226	CcSEcCtD
Epinephrine—Gastrointestinal disorder—Doxorubicin—bone cancer	0.00027	0.0022	CcSEcCtD
Epinephrine—Dizziness—Methotrexate—bone cancer	0.000239	0.00194	CcSEcCtD
Epinephrine—Vomiting—Methotrexate—bone cancer	0.000229	0.00187	CcSEcCtD
Epinephrine—Dizziness—Epirubicin—bone cancer	0.000223	0.00182	CcSEcCtD
Epinephrine—Vomiting—Epirubicin—bone cancer	0.000215	0.00175	CcSEcCtD
Epinephrine—Nausea—Methotrexate—bone cancer	0.000214	0.00175	CcSEcCtD
Epinephrine—Dizziness—Doxorubicin—bone cancer	0.000207	0.00168	CcSEcCtD
Epinephrine—Nausea—Epirubicin—bone cancer	0.000201	0.00163	CcSEcCtD
Epinephrine—Vomiting—Doxorubicin—bone cancer	0.000199	0.00162	CcSEcCtD
Epinephrine—Nausea—Doxorubicin—bone cancer	0.000186	0.00151	CcSEcCtD
Epinephrine—ADRA2C—Signaling by GPCR—SMO—bone cancer	7.43e-05	0.000451	CbGpPWpGaD
Epinephrine—CYP3A4—Metapathway biotransformation—GSTP1—bone cancer	7.43e-05	0.000451	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—GRM1—bone cancer	7.38e-05	0.000448	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—GNA11—bone cancer	7.36e-05	0.000447	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—GNA11—bone cancer	7.34e-05	0.000446	CbGpPWpGaD
Epinephrine—ADRB1—GPCR downstream signaling—IL3—bone cancer	7.33e-05	0.000445	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—SMO—bone cancer	7.31e-05	0.000444	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—GNA11—bone cancer	7.3e-05	0.000444	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—IL3—bone cancer	7.3e-05	0.000443	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—GNA11—bone cancer	7.27e-05	0.000442	CbGpPWpGaD
Epinephrine—ADRA2B—GPCR downstream signaling—IL3—bone cancer	7.26e-05	0.000441	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—MMP2—bone cancer	7.25e-05	0.00044	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—RGS1—bone cancer	7.18e-05	0.000436	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—GRM4—bone cancer	7.18e-05	0.000436	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—GNA11—bone cancer	7.18e-05	0.000436	CbGpPWpGaD
Epinephrine—ADRB2—GPCR downstream signaling—IL3—bone cancer	7.17e-05	0.000435	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—GRM4—bone cancer	7.07e-05	0.000429	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—RGS1—bone cancer	7.07e-05	0.000429	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TGFBR2—bone cancer	7.05e-05	0.000428	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—PLAU—bone cancer	7.04e-05	0.000427	CbGpPWpGaD
Epinephrine—ADRBK1—Innate Immune System—EGFR—bone cancer	6.88e-05	0.000418	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—KIT—bone cancer	6.87e-05	0.000417	CbGpPWpGaD
Epinephrine—PAH—Metabolism—PTGS2—bone cancer	6.86e-05	0.000417	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NDUFA12—bone cancer	6.84e-05	0.000415	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—GNA11—bone cancer	6.79e-05	0.000412	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—ATF1—bone cancer	6.79e-05	0.000412	CbGpPWpGaD
Epinephrine—ADRA2C—GPCR downstream signaling—IL3—bone cancer	6.78e-05	0.000412	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—GRM1—bone cancer	6.73e-05	0.000409	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—GNA11—bone cancer	6.69e-05	0.000406	CbGpPWpGaD
Epinephrine—ADRA1B—GPCR downstream signaling—IL3—bone cancer	6.67e-05	0.000405	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—GRM1—bone cancer	6.67e-05	0.000405	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—IL3—bone cancer	6.65e-05	0.000404	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—IGF1R—bone cancer	6.64e-05	0.000403	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—NT5C3A—bone cancer	6.63e-05	0.000403	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IL3—bone cancer	6.62e-05	0.000402	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—IL3—bone cancer	6.59e-05	0.0004	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—GRM1—bone cancer	6.58e-05	0.0004	CbGpPWpGaD
Epinephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	6.58e-05	0.000399	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—GNA11—bone cancer	6.54e-05	0.000397	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—IL3—bone cancer	6.51e-05	0.000395	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—SMO—bone cancer	6.49e-05	0.000394	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—BRAF—bone cancer	6.46e-05	0.000392	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GRM4—bone cancer	6.28e-05	0.000381	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—RGS1—bone cancer	6.28e-05	0.000381	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—GRM1—bone cancer	6.23e-05	0.000378	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—IL3—bone cancer	6.16e-05	0.000374	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—GRM1—bone cancer	6.13e-05	0.000372	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—GNA11—bone cancer	6.08e-05	0.000369	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—IL3—bone cancer	6.06e-05	0.000368	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—SMO—bone cancer	6.03e-05	0.000366	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—GNA11—bone cancer	5.94e-05	0.000361	CbGpPWpGaD
Epinephrine—ADRA1A—GPCR downstream signaling—IL3—bone cancer	5.93e-05	0.00036	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—MDM2—bone cancer	5.86e-05	0.000356	CbGpPWpGaD
Epinephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	5.84e-05	0.000355	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GRM4—bone cancer	5.83e-05	0.000354	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—RGS1—bone cancer	5.83e-05	0.000354	CbGpPWpGaD
Epinephrine—PAH—Disease—EGFR—bone cancer	5.81e-05	0.000353	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—PLAU—bone cancer	5.72e-05	0.000347	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—ENO2—bone cancer	5.69e-05	0.000346	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—NT5C3A—bone cancer	5.67e-05	0.000344	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TGFBR2—bone cancer	5.66e-05	0.000344	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—ENO2—bone cancer	5.53e-05	0.000336	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—GNA11—bone cancer	5.52e-05	0.000335	CbGpPWpGaD
Epinephrine—ADRA2A—GPCR downstream signaling—IL3—bone cancer	5.51e-05	0.000334	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—MMP9—bone cancer	5.45e-05	0.000331	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GRM1—bone cancer	5.44e-05	0.000331	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—MDM2—bone cancer	5.41e-05	0.000329	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—IL3—bone cancer	5.38e-05	0.000327	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—IGF1R—bone cancer	5.33e-05	0.000324	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—ENO2—bone cancer	5.3e-05	0.000322	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—DHFR—bone cancer	5.28e-05	0.000321	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NDUFA12—bone cancer	5.28e-05	0.00032	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—PTGS2—bone cancer	5.22e-05	0.000317	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—SMO—bone cancer	5.2e-05	0.000316	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—DHFR—bone cancer	5.13e-05	0.000312	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—JUN—bone cancer	5.1e-05	0.000309	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GRM1—bone cancer	5.06e-05	0.000307	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—IL3—bone cancer	5e-05	0.000304	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GNA11—bone cancer	4.93e-05	0.0003	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—DHFR—bone cancer	4.92e-05	0.000299	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—KIT—bone cancer	4.81e-05	0.000292	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GNA11—bone cancer	4.8e-05	0.000291	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—GNA11—bone cancer	4.76e-05	0.000289	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—SMO—bone cancer	4.74e-05	0.000288	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—SMO—bone cancer	4.7e-05	0.000285	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—SMO—bone cancer	4.64e-05	0.000282	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GNA11—bone cancer	4.6e-05	0.000279	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—BRAF—bone cancer	4.52e-05	0.000275	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—ENO2—bone cancer	4.5e-05	0.000273	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—CYP3A4—bone cancer	4.47e-05	0.000272	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—ATF1—bone cancer	4.42e-05	0.000269	CbGpPWpGaD
Epinephrine—TNF—Developmental Biology—EGFR—bone cancer	4.4e-05	0.000267	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—SMO—bone cancer	4.39e-05	0.000266	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling by GPCR—EGFR—bone cancer	4.39e-05	0.000266	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—NT5C3A—bone cancer	4.37e-05	0.000266	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—CYP3A4—bone cancer	4.35e-05	0.000264	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—GNA11—bone cancer	4.34e-05	0.000263	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—SMO—bone cancer	4.32e-05	0.000262	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IL3—bone cancer	4.31e-05	0.000262	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—GNA11—bone cancer	4.3e-05	0.000261	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—GNA11—bone cancer	4.24e-05	0.000258	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—DHFR—bone cancer	4.17e-05	0.000253	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—CYP3A4—bone cancer	4.17e-05	0.000253	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—ATF1—bone cancer	4.03e-05	0.000245	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—GNA11—bone cancer	4.01e-05	0.000244	CbGpPWpGaD
Epinephrine—ADRBK1—Immune System—EGFR—bone cancer	4.01e-05	0.000243	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—ATF1—bone cancer	3.99e-05	0.000243	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—GNA11—bone cancer	3.95e-05	0.00024	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—ATF1—bone cancer	3.94e-05	0.000239	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IL3—bone cancer	3.93e-05	0.000239	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GNA11—bone cancer	3.9e-05	0.000237	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IL3—bone cancer	3.89e-05	0.000236	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—KIT—bone cancer	3.86e-05	0.000235	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IL3—bone cancer	3.84e-05	0.000233	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—SMO—bone cancer	3.84e-05	0.000233	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—GSTP1—bone cancer	3.83e-05	0.000232	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MDM2—bone cancer	3.79e-05	0.00023	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—ATF1—bone cancer	3.73e-05	0.000227	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—GSTP1—bone cancer	3.72e-05	0.000226	CbGpPWpGaD
Epinephrine—ADRBK1—Disease—EGFR—bone cancer	3.7e-05	0.000225	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TGFBR2—bone cancer	3.69e-05	0.000224	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—ATF1—bone cancer	3.67e-05	0.000223	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IL3—bone cancer	3.64e-05	0.000221	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—BRAF—bone cancer	3.63e-05	0.000221	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IL3—bone cancer	3.58e-05	0.000217	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—GSTP1—bone cancer	3.57e-05	0.000217	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—SMO—bone cancer	3.56e-05	0.000216	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—CYP3A4—bone cancer	3.53e-05	0.000215	CbGpPWpGaD
Epinephrine—ADRB3—Signaling by GPCR—EGFR—bone cancer	3.52e-05	0.000214	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—GNA11—bone cancer	3.51e-05	0.000213	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—IGF1R—bone cancer	3.47e-05	0.000211	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TGFBR2—bone cancer	3.36e-05	0.000204	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TGFBR2—bone cancer	3.33e-05	0.000202	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—JUN—bone cancer	3.3e-05	0.0002	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TGFBR2—bone cancer	3.29e-05	0.0002	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—ATF1—bone cancer	3.26e-05	0.000198	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—GNA11—bone cancer	3.26e-05	0.000198	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—MMP9—bone cancer	3.21e-05	0.000195	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IL3—bone cancer	3.18e-05	0.000193	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—IGF1R—bone cancer	3.16e-05	0.000192	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—IGF1R—bone cancer	3.13e-05	0.00019	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TGFBR2—bone cancer	3.11e-05	0.000189	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—IGF1R—bone cancer	3.09e-05	0.000188	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TGFBR2—bone cancer	3.06e-05	0.000186	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MDM2—bone cancer	3.04e-05	0.000185	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—ATF1—bone cancer	3.03e-05	0.000184	CbGpPWpGaD
Epinephrine—ADRA2B—Hemostasis—TP53—bone cancer	3.03e-05	0.000184	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—GSTP1—bone cancer	3.02e-05	0.000184	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IL3—bone cancer	2.95e-05	0.000179	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—IGF1R—bone cancer	2.93e-05	0.000178	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—ENO2—bone cancer	2.9e-05	0.000176	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—IGF1R—bone cancer	2.88e-05	0.000175	CbGpPWpGaD
Epinephrine—ADRA2C—Hemostasis—TP53—bone cancer	2.83e-05	0.000172	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TGFBR2—bone cancer	2.72e-05	0.000165	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—DHFR—bone cancer	2.69e-05	0.000164	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—JUN—bone cancer	2.65e-05	0.000161	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—EGFR—bone cancer	2.59e-05	0.000157	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—MMP9—bone cancer	2.57e-05	0.000156	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—IGF1R—bone cancer	2.56e-05	0.000155	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TGFBR2—bone cancer	2.53e-05	0.000153	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GNA11—bone cancer	2.52e-05	0.000153	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—KIT—bone cancer	2.52e-05	0.000153	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—ENO2—bone cancer	2.48e-05	0.000151	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—IGF1R—bone cancer	2.38e-05	0.000144	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—BRAF—bone cancer	2.37e-05	0.000144	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—DHFR—bone cancer	2.3e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRA2A—Hemostasis—TP53—bone cancer	2.3e-05	0.00014	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—KIT—bone cancer	2.29e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling by GPCR—EGFR—bone cancer	2.29e-05	0.000139	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—CYP3A4—bone cancer	2.28e-05	0.000139	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—KIT—bone cancer	2.27e-05	0.000138	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	2.27e-05	0.000138	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—KIT—bone cancer	2.24e-05	0.000136	CbGpPWpGaD
Epinephrine—ADRBK1—Signaling Pathways—TP53—bone cancer	2.18e-05	0.000132	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—BRAF—bone cancer	2.16e-05	0.000131	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GNA11—bone cancer	2.15e-05	0.000131	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—BRAF—bone cancer	2.14e-05	0.00013	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—KIT—bone cancer	2.12e-05	0.000129	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—BRAF—bone cancer	2.11e-05	0.000128	CbGpPWpGaD
Epinephrine—ADRB1—Signaling by GPCR—EGFR—bone cancer	2.09e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—KIT—bone cancer	2.09e-05	0.000127	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—EGFR—bone cancer	2.08e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling by GPCR—EGFR—bone cancer	2.07e-05	0.000126	CbGpPWpGaD
Epinephrine—ADRB2—Signaling by GPCR—EGFR—bone cancer	2.04e-05	0.000124	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—BRAF—bone cancer	2e-05	0.000121	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MDM2—bone cancer	1.98e-05	0.00012	CbGpPWpGaD
Epinephrine—SLC22A2—Metabolism—PTGS2—bone cancer	1.98e-05	0.00012	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—BRAF—bone cancer	1.96e-05	0.000119	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—GSTP1—bone cancer	1.95e-05	0.000119	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—CYP3A4—bone cancer	1.95e-05	0.000118	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	1.94e-05	0.000118	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling by GPCR—EGFR—bone cancer	1.93e-05	0.000117	CbGpPWpGaD
Epinephrine—ADRA2C—Metabolism—PTGS2—bone cancer	1.93e-05	0.000117	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—ENO2—bone cancer	1.92e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling by GPCR—EGFR—bone cancer	1.9e-05	0.000116	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—KIT—bone cancer	1.86e-05	0.000113	CbGpPWpGaD
Epinephrine—SLC22A1—Metabolism—PTGS2—bone cancer	1.85e-05	0.000112	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MDM2—bone cancer	1.81e-05	0.00011	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MDM2—bone cancer	1.79e-05	0.000109	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—DHFR—bone cancer	1.78e-05	0.000108	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MDM2—bone cancer	1.77e-05	0.000107	CbGpPWpGaD
Epinephrine—ADRB3—Signaling Pathways—TP53—bone cancer	1.75e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—BRAF—bone cancer	1.74e-05	0.000106	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—KIT—bone cancer	1.72e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—JUN—bone cancer	1.72e-05	0.000105	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling by GPCR—EGFR—bone cancer	1.69e-05	0.000103	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—MMP9—bone cancer	1.68e-05	0.000102	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MDM2—bone cancer	1.67e-05	0.000102	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—GSTP1—bone cancer	1.67e-05	0.000101	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GNA11—bone cancer	1.66e-05	0.000101	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MDM2—bone cancer	1.65e-05	9.99e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—BRAF—bone cancer	1.62e-05	9.84e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling by GPCR—EGFR—bone cancer	1.57e-05	9.54e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—JUN—bone cancer	1.57e-05	9.53e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Metabolism—PTGS2—bone cancer	1.57e-05	9.51e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—JUN—bone cancer	1.56e-05	9.45e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—JUN—bone cancer	1.54e-05	9.33e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—MMP9—bone cancer	1.53e-05	9.28e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—MMP9—bone cancer	1.51e-05	9.19e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—MMP9—bone cancer	1.49e-05	9.07e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MDM2—bone cancer	1.46e-05	8.88e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—JUN—bone cancer	1.45e-05	8.83e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—JUN—bone cancer	1.43e-05	8.69e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—MMP9—bone cancer	1.41e-05	8.59e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—MMP9—bone cancer	1.39e-05	8.45e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MDM2—bone cancer	1.36e-05	8.25e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—EGFR—bone cancer	1.35e-05	8.23e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—GSTP1—bone cancer	1.29e-05	7.82e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—JUN—bone cancer	1.27e-05	7.71e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—MMP9—bone cancer	1.24e-05	7.51e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—EGFR—bone cancer	1.23e-05	7.5e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—EGFR—bone cancer	1.22e-05	7.43e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—EGFR—bone cancer	1.21e-05	7.33e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—JUN—bone cancer	1.18e-05	7.17e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—MMP9—bone cancer	1.15e-05	6.97e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—EGFR—bone cancer	1.14e-05	6.94e-05	CbGpPWpGaD
Epinephrine—ADRA1D—Signaling Pathways—TP53—bone cancer	1.14e-05	6.91e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—EGFR—bone cancer	1.12e-05	6.83e-05	CbGpPWpGaD
Epinephrine—ADRB1—Signaling Pathways—TP53—bone cancer	1.04e-05	6.29e-05	CbGpPWpGaD
Epinephrine—ADRA2B—Signaling Pathways—TP53—bone cancer	1.03e-05	6.24e-05	CbGpPWpGaD
Epinephrine—ADRB2—Signaling Pathways—TP53—bone cancer	1.01e-05	6.16e-05	CbGpPWpGaD
Epinephrine—CYP2C9—Metabolism—PTGS2—bone cancer	1.01e-05	6.14e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—EGFR—bone cancer	9.99e-06	6.07e-05	CbGpPWpGaD
Epinephrine—ADRA2C—Signaling Pathways—TP53—bone cancer	9.59e-06	5.83e-05	CbGpPWpGaD
Epinephrine—ADRA1B—Signaling Pathways—TP53—bone cancer	9.44e-06	5.73e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—EGFR—bone cancer	9.28e-06	5.64e-05	CbGpPWpGaD
Epinephrine—CYP1A2—Metabolism—PTGS2—bone cancer	8.64e-06	5.25e-05	CbGpPWpGaD
Epinephrine—ADRA1A—Signaling Pathways—TP53—bone cancer	8.39e-06	5.09e-05	CbGpPWpGaD
Epinephrine—ADRA2A—Signaling Pathways—TP53—bone cancer	7.79e-06	4.73e-05	CbGpPWpGaD
Epinephrine—CYP3A4—Metabolism—PTGS2—bone cancer	6.67e-06	4.05e-05	CbGpPWpGaD
